Published in J Exp Med on May 01, 1990
Retinoids are important cofactors in T cell activation. J Exp Med (1992) 1.29
Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes. J Cell Biol (1991) 1.15
Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology. J Exp Med (1993) 1.14
An essential ligand-binding domain in the membrane receptor for retinol-binding protein revealed by large-scale mutagenesis and a human polymorphism. J Biol Chem (2008) 1.12
Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells. J Exp Med (1993) 1.05
Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J (2009) 0.97
The membrane receptor for plasma retinol-binding protein, a new type of cell-surface receptor. Int Rev Cell Mol Biol (2011) 0.94
Retro-retinoids in regulated cell growth and death. J Exp Med (1996) 0.93
Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation. FASEB J (2008) 0.90
Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A. PLoS One (2014) 0.89
The effects of retinol on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Clin Exp Immunol (1993) 0.82
Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children. Clin Diagn Lab Immunol (1994) 0.81
Vitamin A in serum is a survival factor for fibroblasts. Proc Natl Acad Sci U S A (1997) 0.81
Techniques to study specific cell-surface receptor-mediated cellular vitamin A uptake. Methods Mol Biol (2010) 0.79
Gene regulation network inference with joint sparse Gaussian graphical models. J Comput Graph Stat (2014) 0.76
The role of vitamins in cystic fibrosis. J R Soc Med (2000) 0.75
Retinol as a cofactor for PKCδ-mediated impairment of insulin sensitivity in a mouse model of diet-induced obesity. FASEB J (2015) 0.75
Impaired human responses to tetanus toxoid in vitamin A-deficient SCID mice reconstituted with human peripheral blood lymphocytes. Infect Immun (1995) 0.75
A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (1988) 9.07
The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell (1978) 6.82
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A (1980) 6.65
TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN. J Exp Med (1925) 6.38
Identification of a second human retinoic acid receptor. Nature (1988) 5.11
Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol (1978) 4.47
Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest (1968) 3.52
A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature (1988) 3.33
The three-dimensional structure of retinol-binding protein. EMBO J (1984) 2.82
Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. Cancer Res (1983) 1.85
Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus. J Exp Med (1984) 1.69
Embryology: we have a morphogen! Nature (1987) 1.47
Histology of the lesions produced in the reproductive tract of animals fed a diet deficient in vitamin A alcohol but containing vitamin A acid. I. The male rat. J Reprod Fertil (1963) 1.25
The effect of excess vitamin A on cultures of embryonic chicken skin explanted at different stages of differentiation. Proc R Soc Lond B Biol Sci (1956) 1.21
Retinoic acid: an endogenous compound of human blood. Unequivocal demonstration of endogenous retinoic acid in normal physiological conditions. Anal Biochem (1979) 1.05
All-trans-retinoic acid: measurement of reference values in human serum by high performance liquid chromatography. J Lipid Res (1982) 1.05
Molecular dynamics simulations of the holo and apo forms of retinol binding protein. Structural and dynamical changes induced by retinol removal. J Mol Biol (1986) 1.04
Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun (1980) 1.01
Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells. J Immunol (1987) 1.01
Purification of prealbumin from human and canine serum using a two-step affinity chromatographic procedure. Eur J Biochem (1977) 0.90
Effect of all-trans retinol and retinoic acid nutriture on the immune system of chicks. J Nutr (1983) 0.89
Survival of germfree rats without vitamin A. Science (1969) 0.88
Characterization of bovine plasma retinol-binding protein and evidence for lack of binding between it and other bovine plasma proteins. J Biol Chem (1975) 0.86
The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science (1998) 39.86
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
The yeast nuclear pore complex: composition, architecture, and transport mechanism. J Cell Biol (2000) 10.20
Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal Chem (1991) 5.62
Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Acad Sci U S A (1999) 4.76
Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice. Immunol Rev (1979) 4.31
Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell (1996) 3.88
G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology (1992) 3.79
Structure of the RCK domain from the E. coli K+ channel and demonstration of its presence in the human BK channel. Neuron (2001) 3.62
Structural conservation in prokaryotic and eukaryotic potassium channels. Science (1998) 3.61
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem (2000) 3.42
Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol (2001) 3.31
Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell (1998) 3.22
Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol (2001) 3.14
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
Synthesis and use of O-stearoyl polysaccharides in passive hemagglutination and hemolysis. Eur J Biochem (1967) 2.99
Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science (1985) 2.94
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62
Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies. J Exp Med (1979) 2.58
Structural similarity between TAFs and the heterotetrameric core of the histone octamer. Nature (1996) 2.58
Structure of the peptide network of pneumococcal peptidoglycan. J Biol Chem (1987) 2.45
Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc Natl Acad Sci U S A (1982) 2.33
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer (1999) 2.26
Evidence for surface-associated immunoglobulin on T and B lymphocytes. Eur J Immunol (1971) 2.25
Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr Opin Chem Biol (2001) 2.22
Conformational changes in proteins probed by hydrogen-exchange electrospray-ionization mass spectrometry. Rapid Commun Mass Spectrom (1991) 2.22
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med (1998) 2.20
Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12
Protein identification using mass spectrometric information. Electrophoresis (1998) 2.11
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol (1994) 2.10
Assay to determine plastic deformations of bones in the micron range. Res Exp Med (Berl) (1973) 2.09
A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem (1997) 2.08
Lipid synthesis under hydrothermal conditions by Fischer-Tropsch-type reactions. Orig Life Evol Biosph (1999) 2.00
A robust, detergent-friendly method for mass spectrometric analysis of integral membrane proteins. Anal Chem (2000) 2.00
Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal Chem (1996) 1.97
Rapid, sensitive analysis of protein mixtures by mass spectrometry. Proc Natl Acad Sci U S A (1990) 1.96
Probing the solution structure of the DNA-binding protein Max by a combination of proteolysis and mass spectrometry. Protein Sci (1995) 1.90
Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Anal Chem (1998) 1.90
Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology (1982) 1.88
Preparation of lymphocyte-specific antibody from anti-lymphocyte serum. Lancet (1968) 1.85
New visual markers of antibody for electron microscopy. Nature (1969) 1.83
The cost of intensive care: a comparison on one unit between 1988 and 1991. Intensive Care Med (1994) 1.79
Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med (1994) 1.75
Domain organization of the Escherichia coli RNA polymerase sigma 70 subunit. J Mol Biol (1996) 1.73
Redox regulation of cell signalling. Nature (1996) 1.72
Nup2p dynamically associates with the distal regions of the yeast nuclear pore complex. J Cell Biol (2001) 1.71
Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. EMBO J (1998) 1.68
The home health visit: an appropriate unit for Medicare payment? Health Aff (Millwood) (1996) 1.67
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med (2000) 1.67
Ontogeny of murine B lymphocytes: sequence of B-cell differentiation from surface-immunoglobulin-negative precursors to plasma cells. Proc Natl Acad Sci U S A (1976) 1.64
An electrospray-ionization mass spectrometer with new features. Rapid Commun Mass Spectrom (1990) 1.64
The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61
Second-order schedules: comparison of different procedures for scheduling paired and nonpaired brief stimuli. J Exp Anal Behav (1972) 1.60
Tests of behavior momentum in simple and multiple schedules with rats and pigeons. J Exp Anal Behav (1993) 1.58
Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet (1992) 1.56
Monoclonal antibodies against murine cell surface antigens: anti-H-2, anti-Ia and anti-T cell antibodies. Curr Top Microbiol Immunol (1978) 1.55
Automatic identification of proteins with a MALDI-quadrupole ion trap mass spectrometer. Anal Chem (2001) 1.53
Cinnamic acid derivatives as matrices for ultraviolet laser desorption mass spectrometry of proteins. Rapid Commun Mass Spectrom (1989) 1.51
Topographical location of H-Y antigen on mouse spermatozoa by immunoelectronmicroscopy. Proc Natl Acad Sci U S A (1973) 1.50
Heat-induced conformational changes in proteins studied by electrospray ionization mass spectrometry. Anal Chem (1993) 1.49
A pharmacological examination of the resistance-to-change hypothesis of response strength. J Exp Anal Behav (1986) 1.49
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Cancer Res (2001) 1.47
Structural features and selective expression of three Ly-5+ cell-surface molecules. Immunogenetics (1981) 1.47
Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg (2001) 1.45
[Experimental investigations of the elastic deformation by compression of bone diaphyses (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 1.45
Human TATA-binding protein-related factor-2 (hTRF2) stably associates with hTFIIA in HeLa cells. Proc Natl Acad Sci U S A (1999) 1.44
Altered peptidoglycan structure in a pneumococcal transformant resistant to penicillin. J Bacteriol (1988) 1.44
Matrix-assisted laser desorption ionization mass-spectrometry of proteins. Methods Enzymol (1996) 1.44
[Experimental studies on the mechanical properties of bone with reference to compression osteosyntheses]. Arch Orthop Unfallchir (1973) 1.44
High-accuracy molecular mass determination of proteins using matrix-assisted laser desorption mass spectrometry. Anal Chem (1990) 1.43
[Biomechanical caused of loosening and breaking of the hip joint prothesess (author's transl)]. Arch Orthop Unfallchir (1973) 1.43
Rapidly switchable matrix-assisted laser desorption/ionization and electrospray quadrupole-time-of-flight mass spectrometry for protein identification. J Am Soc Mass Spectrom (2000) 1.42
Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry (1993) 1.42
Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet (1996) 1.41
["Zuggurtungs"-hip joint endoprosthesis (author's transl)]. Arch Orthop Unfallchir (1976) 1.39
Factors affecting the ultraviolet laser desorption of proteins. Rapid Commun Mass Spectrom (1989) 1.38
Ongoing debate over 'complete' physicals. Postgrad Med (1999) 1.37
Studies of the mouse Ly-6 alloantigen system. II. Complexities of the Ly-6 region. Immunogenetics (1984) 1.36
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci U S A (2000) 1.36
Ly-m11: the H-3 region of mouse chromosome 2 controls a new surface alloantigen. Immunogenetics (1980) 1.36
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1997) 1.36
Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k. Eur J Immunol (1982) 1.35
A strategy for rapid, high-confidence protein identification. Anal Chem (1997) 1.33
Mouse alloantibodies capable of blocking cytotoxic T cell function. II. Further study on the relationship between the blocking antibodies and the products of the Lyt-2 locus. Eur J Immunol (1980) 1.33
N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C.2. J Immunol (1988) 1.32
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J Biol Chem (2000) 1.32